Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
Background. Serum creatinine is suboptimal as a biomarker in the early diagnosis of contrast-induced nephropathy (CIN). In this study, we investigated a panel of novel biomarkers in the early diagnosis of CIN and in assessing patient outcomes. Methods. This single-centre, nested, prospective case-co...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2020/8568139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565989412175872 |
---|---|
author | Justor Banda Raquel Duarte Therese Dix-Peek Caroline Dickens Pravin Manga Saraladevi Naicker |
author_facet | Justor Banda Raquel Duarte Therese Dix-Peek Caroline Dickens Pravin Manga Saraladevi Naicker |
author_sort | Justor Banda |
collection | DOAJ |
description | Background. Serum creatinine is suboptimal as a biomarker in the early diagnosis of contrast-induced nephropathy (CIN). In this study, we investigated a panel of novel biomarkers in the early diagnosis of CIN and in assessing patient outcomes. Methods. This single-centre, nested, prospective case-controlled study included 30 patients with CIN and 60 matched controls. Serum and urine samples were collected before contrast administration and at 24 hours, 48 hours, and ≥5 days after contrast administration. Concentrations of NGAL, cystatin C, β2M, IL18, IL10, KIM1, and TNFα were determined using Luminex and ELISA assays. Outcomes were biomarker diagnostic discrimination performance for CIN and mortality after generation of area under receiver operating characteristic curves (AUROCs). Results. Median serum levels for 24 h cystatin C (p<0.01) and 48 h β2M levels (p<0.001) and baseline urine NGAL (p=0.02) were higher in CIN patients compared to controls with AUROCs of 0.75, 0.78, and 0.74, respectively, for the early diagnosis of CIN. Serum β2M levels were higher in CIN patients at all time points. Elevated baseline serum concentrations of IL18 (p<0.001), β2M (p=0.04), TNFα (p<0.001), and baseline urine KIM (p=0.01) and 24 h urine NGAL (p=0.02) were significantly associated with mortality. Baseline serum concentrations of IL18, β2M, and TNFα showed the best discrimination performance for mortality with AUROCs, all >0.80. Baseline NGAL was superior for excluding patients at risk for CIN, with positive and negative predictive ranges of 0.50–0.55 and 0.81–0.88, respectively. Cystatin C (p=0.003) and β2M (p=0.03) at 24 h independently predicted CIN risk. β2M predicted increased mortality of 40% at baseline and 50% at 24 hours. Conclusion. Serum cystatin C at 24 h was the best biomarker for CIN diagnosis, while baseline levels of serum IL18, β2M, and TNFα were best for predicting prognosis. |
format | Article |
id | doaj-art-455c7387838c4dcda775a1337f83f0b8 |
institution | Kabale University |
issn | 2090-214X 2090-2158 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Nephrology |
spelling | doaj-art-455c7387838c4dcda775a1337f83f0b82025-02-03T01:05:24ZengWileyInternational Journal of Nephrology2090-214X2090-21582020-01-01202010.1155/2020/85681398568139Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced NephropathyJustor Banda0Raquel Duarte1Therese Dix-Peek2Caroline Dickens3Pravin Manga4Saraladevi Naicker5Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDivision of Cardiology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South AfricaDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaBackground. Serum creatinine is suboptimal as a biomarker in the early diagnosis of contrast-induced nephropathy (CIN). In this study, we investigated a panel of novel biomarkers in the early diagnosis of CIN and in assessing patient outcomes. Methods. This single-centre, nested, prospective case-controlled study included 30 patients with CIN and 60 matched controls. Serum and urine samples were collected before contrast administration and at 24 hours, 48 hours, and ≥5 days after contrast administration. Concentrations of NGAL, cystatin C, β2M, IL18, IL10, KIM1, and TNFα were determined using Luminex and ELISA assays. Outcomes were biomarker diagnostic discrimination performance for CIN and mortality after generation of area under receiver operating characteristic curves (AUROCs). Results. Median serum levels for 24 h cystatin C (p<0.01) and 48 h β2M levels (p<0.001) and baseline urine NGAL (p=0.02) were higher in CIN patients compared to controls with AUROCs of 0.75, 0.78, and 0.74, respectively, for the early diagnosis of CIN. Serum β2M levels were higher in CIN patients at all time points. Elevated baseline serum concentrations of IL18 (p<0.001), β2M (p=0.04), TNFα (p<0.001), and baseline urine KIM (p=0.01) and 24 h urine NGAL (p=0.02) were significantly associated with mortality. Baseline serum concentrations of IL18, β2M, and TNFα showed the best discrimination performance for mortality with AUROCs, all >0.80. Baseline NGAL was superior for excluding patients at risk for CIN, with positive and negative predictive ranges of 0.50–0.55 and 0.81–0.88, respectively. Cystatin C (p=0.003) and β2M (p=0.03) at 24 h independently predicted CIN risk. β2M predicted increased mortality of 40% at baseline and 50% at 24 hours. Conclusion. Serum cystatin C at 24 h was the best biomarker for CIN diagnosis, while baseline levels of serum IL18, β2M, and TNFα were best for predicting prognosis.http://dx.doi.org/10.1155/2020/8568139 |
spellingShingle | Justor Banda Raquel Duarte Therese Dix-Peek Caroline Dickens Pravin Manga Saraladevi Naicker Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy International Journal of Nephrology |
title | Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy |
title_full | Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy |
title_fullStr | Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy |
title_full_unstemmed | Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy |
title_short | Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy |
title_sort | biomarkers for diagnosis and prediction of outcomes in contrast induced nephropathy |
url | http://dx.doi.org/10.1155/2020/8568139 |
work_keys_str_mv | AT justorbanda biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy AT raquelduarte biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy AT theresedixpeek biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy AT carolinedickens biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy AT pravinmanga biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy AT saraladevinaicker biomarkersfordiagnosisandpredictionofoutcomesincontrastinducednephropathy |